David Ropeik’s 2011 opinion article “Not Being Vaccinated Is Not Acceptable” argues that vaccination decisions can create risks and costs for people beyond the individual who refuses a vaccine (Ropeik, 2011). His central claim is that personal liberty has limits when one person’s decision increases the probability of preventable harm to others. He uses vaccine-preventable disease as an example of this broader principle and compares refusal with other socially regulated risks.
A current critical review needs to separate three questions that Ropeik sometimes blends together. The first is empirical: are recommended vaccines effective and acceptably safe? The second is ethical: when does an individual medical decision create enough external risk to justify collective intervention? The third is policy-based: what type of response—education, access programs, school requirements, workplace rules, isolation, quarantine, or another measure—is proportionate in a particular setting? These questions are related, but evidence supporting vaccination does not automatically determine one universal policy response.
Ropeik’s Argument
Ropeik’s strongest point is that infectious disease differs from many other personal health choices because infection can spread. A decision affecting vaccination status may therefore influence infants too young for routine vaccination, immunocompromised patients, pregnant people without immunity, or other individuals who do not receive full protection from vaccination. This is the external-risk argument at the center of his article.
Measles remains a useful example because it is extremely contagious. The World Health Organization (WHO) reported in July 2026 that measles vaccination prevented nearly 59 million deaths between 2000 and 2024, yet approximately 95,000 measles deaths still occurred globally in 2024, mostly among unvaccinated or under-vaccinated young children (WHO, 2026a). The Centers for Disease Control and Prevention (CDC) notes that measles can remain infectious in an airspace for up to two hours after an infected person leaves and that an infected person can spread the virus before recognizing the illness (CDC, 2026a).
These characteristics support Ropeik’s claim that infection risk cannot always be confined to the person making the original decision. However, the article’s rhetoric sometimes treats vaccine refusal as one uniform behavior. In reality, undervaccination can result from different causes: access barriers, missed appointments, misinformation, specific safety concerns, distrust of institutions, administrative problems, or deliberate ideological refusal. A policy or communication strategy that does not distinguish these causes may respond poorly to the actual problem.
Ropeik also emphasizes the public costs of outbreaks. Contact tracing, laboratory testing, post-exposure prophylaxis, staff time, emergency response, school disruption, and treatment can create large costs even when the number of confirmed cases is relatively small. Economic effects strengthen the public-health case for prevention, although cost should not replace the more important issue of preventable illness and death.
Evidence Base
The empirical case for measles vaccination is strong. CDC’s 2026 guidance reports that one dose of measles-containing vaccine is about 93 percent effective against measles and two doses are about 97 percent effective (CDC, 2026b). No vaccine is perfectly effective, so community coverage still matters. Breakthrough infections can occur, particularly after intense exposure, but they are uncommon.
Vaccine safety should be described with the same precision. Vaccines can cause adverse effects, most of which are mild and temporary, while rare serious events are addressed through ongoing safety monitoring (WHO, 2025c). Rare serious reactions can occur and are monitored through safety systems. A credible review should therefore avoid claiming that vaccines are “risk free.” The relevant comparison is between the known risks of vaccination and the risks associated with infection, transmission, and complications.
The autism question is especially important because it has influenced vaccine hesitancy for decades. WHO’s Global Advisory Committee on Vaccine Safety reviewed evidence published from 2010 through August 2025 and reaffirmed in December 2025 that the evidence does not support a causal relationship between vaccines and autism spectrum disorder. The review examined 31 primary studies from multiple countries and also assessed concerns involving thiomersal and aluminium-containing vaccines (WHO, 2025a, 2025b).
This conclusion matters because the original autism claim gained public attention after a 1998 paper concerning MMR vaccination. That paper was later retracted and associated with serious misconduct. Repetition of the claim after its evidentiary basis collapsed demonstrates how medical misinformation can persist through emotionally powerful stories even when large epidemiological studies do not support the alleged causal relationship.
Communication should nevertheless avoid dismissing all concern as irrational. Parents may observe that autism traits become noticeable during the same developmental period in which children receive routine vaccinations. Temporal coincidence can feel causally meaningful even when population evidence shows otherwise. Clinicians can respond more effectively by explaining how causal inference works rather than simply telling families not to ask questions.
The evidence on isolation also challenges one part of the original student response to Ropeik. The earlier review objected broadly to asking infected people to remain at home because doing so might discourage treatment. That concern about stigma and concealment is relevant, but measles control does require limiting exposure during the contagious period. CDC’s August 2026 public guidance instructs people with measles to remain home through the fifth day after rash onset and to avoid exposing other people while arranging medical care appropriately (CDC, 2026c).
Policy Questions
Vaccination policy is not one single issue. School requirements, healthcare-worker policies, outbreak exclusion, occupational vaccination, and general adult recommendations involve different risk environments. Public-health ethics typically evaluates such measures through factors such as disease severity, transmission risk, intervention effectiveness, medical exemptions, access, proportionality, and whether less restrictive alternatives can achieve the same goal.
Medical exemptions are essential because some individuals should not receive a particular vaccine or should delay vaccination because of a recognized contraindication or clinical condition. Their existence strengthens the externality problem because people unable to receive vaccination may depend partly on lower community transmission.
Nonmedical exemptions are more contested because they involve conscience, parental authority, public risk, and institutional responsibility. Jurisdictions differ in how they approach religious or personal-belief exemptions, and the appropriate legal framework depends on local law. A neutral analysis should therefore distinguish evidence about transmission from normative questions about how much authority schools or governments should exercise.
Access must also be separated from refusal. A policy can be inequitable if people are penalized for missing vaccination while clinics are distant, appointments unavailable, records difficult to retrieve, or vaccines unaffordable. Mobile clinics, school-based programs, reminders, paid time, language access, and simplified documentation address access problems directly. Treating every missed dose as ideological opposition can obscure structural barriers.
Isolation and quarantine require another distinction. Isolation applies to people who are known or believed to be infected, while quarantine concerns people who may have been exposed but are not yet known to be ill. Because quarantine restricts people who may never become sick, it generally requires stronger justification and careful attention to duration, due process, support, and exposure evidence.
Contact tracing is less restrictive but can still create privacy concerns. Its purpose is to identify people who may need vaccination, immune globulin, monitoring, testing, or temporary precautions. Public cooperation is more likely when health agencies collect only necessary information and explain how data will be used.
Healthcare settings create additional considerations because patients may be unusually vulnerable. Vaccination policies for staff are often evaluated according to the disease, worker role, patient population, vaccine effectiveness, medical accommodation, and availability of alternative controls. A single rule for every vaccine and every healthcare position would ignore meaningful differences in exposure and transmission.
Critical Assessment
Ropeik’s article is persuasive when it argues that vaccine decisions can create external effects and that infectious-disease policy cannot be analyzed only as a matter of private preference. Current measles evidence supports the factual foundation of that claim: the disease is highly transmissible, vaccination is highly effective, and outbreaks can affect people who are unable to rely entirely on their own vaccination status.
The article is less persuasive when its title and tone compress very different forms of undervaccination into a single moral category. A person unable to access care, a parent with one specific safety question, and a committed opponent of all vaccination are not the same policy problem. Condemnation may communicate urgency, but it can also reduce opportunities for productive dialogue when uncertainty or distrust is the main barrier.
Ropeik’s harm-based reasoning also does not settle every mandate question automatically. Evidence that vaccination reduces risk establishes an important factual premise, while decisions about requirements still involve legal authority, proportionality, exemptions, distribution of burdens, and the feasibility of alternatives. Those questions should be analyzed explicitly rather than hidden inside a general statement that vaccination is socially beneficial.
The same balance applies to communication. Public agencies weaken trust when they imply that serious adverse events are literally impossible. They also weaken trust when they present unsupported claims as if they deserve equal evidentiary weight with large, replicated studies. Accurate communication recognizes that medical interventions have benefits and risks while explaining why the current balance of evidence supports particular recommendations.
The strongest contemporary reading of Ropeik is therefore narrower than the title suggests. His article correctly identifies vaccination as a decision with community consequences, but an effective public-health response depends on context. Evidence, access, medical exemptions, isolation when infectious, transparent safety monitoring, and proportionate institutional rules address different parts of the problem. The critical issue is not whether individual choice or community protection always wins; it is how evidence and ethics are combined for a specific disease, setting, and population.
Works Cited
Centers for Disease Control and Prevention. (2026a). How Measles Spreads.
Centers for Disease Control and Prevention. (2026b). Measles Vaccine Recommendations.
Centers for Disease Control and Prevention. (2026c). Measles: What to Do If You Get Sick or Exposed.
Ropeik, David. “Not Being Vaccinated Is Not Acceptable.” Los Angeles Times, 24 July 2011.
World Health Organization. (2025a). WHO Expert Group’s New Analysis Reaffirms There Is No Link Between Vaccines and Autism.
World Health Organization. (2025b). Vaccines, Thimerosal and Autism Spectrum Disorder: Evidence Review 2010–2025.
World Health Organization. (2026a). Measles.
World Health Organization. (2025c). Vaccines and Immunization: Vaccine Safety.
Academic Master Education Team is a group of academic editors and subject specialists responsible for producing structured, research-backed essays across multiple disciplines. Each article is developed following Academic Master’s Editorial Policy and supported by credible academic references. The team ensures clarity, citation accuracy, and adherence to ethical academic writing standards
Content reviewed under Academic Master Editorial Policy.
